1. Stocks
    2. /
  2. Pfizer (NYSE: PFE)
    3. /

Pfizer (NYSE: PFE) Share Price and News

$26.01 $-0.21 (-0.8%) 16 June 2026 at 5:58:59 am AEST

Pfizer Chart and Price Data

About Pfizer

Last updated 16-06-2026, 05:58:59am AEST
Current Price $26.01
Change $-0.21 (-0.8%)
Close Price $26.01
Open Price $26.25
Bid $26.00
Ask $26.01
Day Range $25.98 - $26.42
Year Range $23.11 - $28.75
Volume 1,185,017
Average Volume 36,537,248
Market Cap $148,185,440,000.00
Earnings Per Share $1.30

    • Pfizer (NYSE: PFE)
    Latest News

    asx share associated with COVID vaccine represented by lab tech drawing down syringe
    International Stock News

    Pfizer to develop mRNA vaccines without BioNTech

    | Cory Renauer

    The pharmaceutical heavyweight thinks it won't need any more help to whip up new mRNA-based vaccines.

    Read more »

    coronavirus vaccine represented by gloved hand drawing down from syringe
    International Stock News

    Johnson & Johnson coronavirus vaccine wins FDA authorisation

    | Eric Volkman

    The big pharmaceutical company's jab has some important advantages.

    Read more »

    covid vaccine shares represented by numbers 2021 with the one displayed as syringe
    Coronavirus News

    Pfizer COVID-19 vaccine given green light for use in Australia

    | Mitchell Lawler

    The TGA has approved the Pfizer COVID-19 vaccine for use in Australia. We take a look at some of the…

    Read more »

    Stock chart overlaid on map on a laptop
    Share Market News

    CV Check (ASX:CV1) share price flat on results update

    | Aaron Teboneras

    The CV Check Ltd (ASX: CV1) share price remains unchanged today following the release of its Q2 FY21 scorecard.

    Read more »

    Hand with blue medical gloves holds vials of coronavirus vaccines
    International Stock News

    Moderna's stock has surged 488% in 2020: Is it a buy for 2021?

    | Sushree Mohanty

    This smaller biotech company attracted a lot of attention in 2020, but is it still worth an investment?

    Read more »

    asx share price boosted by us investment represented by hand waving US flag across winning athlete
    Share Market News

    Here are the US shares ASX investors are buying

    | Sebastian Bowen

    AirBnB Inc (NASDAQ: ABNB) and Tesla Inc (NASDAQ: TSLA) were amongst the US shares that ASX investors were buying last…

    Read more »

    Vaccine vials sitting on top of a pile of US cash
    International Stock News

    The most popular coronavirus stock may lose half its value by 2023

    | Sean Williams

    This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward.

    Read more »

    vials of medication labelled with COVID-19 vaccine stickers
    Share Market News

    CSL (ASX:CSL) share price on watch after hints of 'far more robust' vaccine

    | Bernd Struben

    Australian global biotech giant CSL Limited didn't win the sprint for a coronavirus vaccine. But it may lead the marathon.

    Read more »

    woman waering face mask holding vial of covid-19 vaccine
    International Stock News

    Why Pfizer and BioNTech stocks popped Wednesday

    | Joe Tenebruso

    The healthcare leaders became the first to receive emergency authorization for their coronavirus vaccine.

    Read more »

    travel asx share price represented by suitcase wearing covid mask
    Share Gainers

    Which ASX travel shares performed the best in November? 

    | Lina Lim

    On the back of vaccine hopes and reopening borders, which ASX travel shares performed the best in November? We take…

    Read more »

    doctor holding covid-19 vaccine bottle
    International Stock News

    3 key advantages Moderna holds over Pfizer and AstraZeneca

    | Keith Speights

    They could add up to make Moderna a much bigger winner for investors than either of the two big pharma…

    Read more »

    Doctor holding small world globe in one hand and a Covid vaccine needle in the other
    International Stock News

    Why AstraZeneca's potential vaccine is more exciting than you think

    | Jason Hawthorne

    Investors are missing the big picture in the drugmaker's vaccine announcement.

    Read more »

    Profile

    since

    Note